| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.00B | +3.5% |
| Cost of Revenue | $1.20B | +3.8% |
| Gross Profit | $2.80B | +3.4% |
| R&D Expense | $364.2M | +5.0% |
| SG&A Expense | $1.76B | +3.5% |
| Operating Income | $607.6M | -5.6% |
| Pre-tax Income | $609.0M | -5.0% |
| Income Tax | $187.6M | -4.4% |
| Net Income | $421.4M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.04B | +11.4% |
| Accounts Receivable | $995.7M | +10.2% |
| Inventory | $254.3M | -14.4% |
| Current Assets | $2.49B | +1.9% |
| Total Assets | $6.21B | +2.1% |
| Current Liabilities | $2.04B | -1.4% |
| Total Liabilities | $2.36B | -3.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $738.2M | -6.1% |
| Capital Expenditures | $115.6M | -35.0% |
| Investing Cash Flow | -$254.9M | -30.1% |
| Financing Cash Flow | -$355.7M | +40.5% |
| Free Cash Flow | $622.7M | +2.4% |
| -5.3% |
| EPS (Basic) | $5.63 | -3.3% |
| EPS (Diluted) | $5.62 | -3.3% |
| Stockholders' Equity |
| $3.85B |
| +6.1% |